La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Parkin mitochondria in the autophagosome.

Identifieur interne : 000F28 ( PubMed/Checkpoint ); précédent : 000F27; suivant : 000F29

Parkin mitochondria in the autophagosome.

Auteurs : Heidi M. Mcbride [Canada]

Source :

RBID : pubmed:19029341

English descriptors

Abstract

Narendra et al. (see p. 795 of this issue) have made an exciting new discovery that links the fields of mitochondrial quality control and the genetics of Parkinson's disease (PD). Through an elegant series of high-resolution imaging experiments, they are the first to provide evidence that the PARK2 gene product Parkin is selectively recruited to damaged or uncoupled mitochondria. This recruitment leads to the clearance of the organelles through the autophagosome, demonstrating a primary function for Parkin in the regulation of mitochondrial turnover. This work significantly increases our understanding of PD and provides a new framework for the development of therapeutic interventions.

DOI: 10.1083/jcb.200810184
PubMed: 19029341


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:19029341

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Parkin mitochondria in the autophagosome.</title>
<author>
<name sortKey="Mcbride, Heidi M" sort="Mcbride, Heidi M" uniqKey="Mcbride H" first="Heidi M" last="Mcbride">Heidi M. Mcbride</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7, Canada. hmcbride@ottawaheart.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7</wicri:regionArea>
<wicri:noRegion>Ontario K1Y 4W7</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:19029341</idno>
<idno type="pmid">19029341</idno>
<idno type="doi">10.1083/jcb.200810184</idno>
<idno type="wicri:Area/PubMed/Corpus">000F29</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F29</idno>
<idno type="wicri:Area/PubMed/Curation">000F29</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F29</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F29</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F29</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Parkin mitochondria in the autophagosome.</title>
<author>
<name sortKey="Mcbride, Heidi M" sort="Mcbride, Heidi M" uniqKey="Mcbride H" first="Heidi M" last="Mcbride">Heidi M. Mcbride</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7, Canada. hmcbride@ottawaheart.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7</wicri:regionArea>
<wicri:noRegion>Ontario K1Y 4W7</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of cell biology</title>
<idno type="eISSN">1540-8140</idno>
<imprint>
<date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Autophagy (drug effects)</term>
<term>Fibroblasts (enzymology)</term>
<term>Humans</term>
<term>Membrane Potential, Mitochondrial</term>
<term>Mitochondria (drug effects)</term>
<term>Mitochondria (enzymology)</term>
<term>Mitochondria (ultrastructure)</term>
<term>Neurons (enzymology)</term>
<term>Parkinson Disease (enzymology)</term>
<term>Parkinson Disease (pathology)</term>
<term>Protein Transport</term>
<term>Recombinant Fusion Proteins (metabolism)</term>
<term>Signal Transduction</term>
<term>Time Factors</term>
<term>Ubiquitin-Protein Ligases (genetics)</term>
<term>Ubiquitin-Protein Ligases (metabolism)</term>
<term>Uncoupling Agents (pharmacology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Ubiquitin-Protein Ligases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Recombinant Fusion Proteins</term>
<term>Ubiquitin-Protein Ligases</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Autophagy</term>
<term>Mitochondria</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Fibroblasts</term>
<term>Mitochondria</term>
<term>Neurons</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Uncoupling Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="ultrastructure" xml:lang="en">
<term>Mitochondria</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Membrane Potential, Mitochondrial</term>
<term>Protein Transport</term>
<term>Signal Transduction</term>
<term>Time Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Narendra et al. (see p. 795 of this issue) have made an exciting new discovery that links the fields of mitochondrial quality control and the genetics of Parkinson's disease (PD). Through an elegant series of high-resolution imaging experiments, they are the first to provide evidence that the PARK2 gene product Parkin is selectively recruited to damaged or uncoupled mitochondria. This recruitment leads to the clearance of the organelles through the autophagosome, demonstrating a primary function for Parkin in the regulation of mitochondrial turnover. This work significantly increases our understanding of PD and provides a new framework for the development of therapeutic interventions.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">19029341</PMID>
<DateCreated>
<Year>2008</Year>
<Month>12</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2008</Year>
<Month>12</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>11</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1540-8140</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>183</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2008</Year>
<Month>Dec</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of cell biology</Title>
<ISOAbbreviation>J. Cell Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Parkin mitochondria in the autophagosome.</ArticleTitle>
<Pagination>
<MedlinePgn>757-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1083/jcb.200810184</ELocationID>
<Abstract>
<AbstractText>Narendra et al. (see p. 795 of this issue) have made an exciting new discovery that links the fields of mitochondrial quality control and the genetics of Parkinson's disease (PD). Through an elegant series of high-resolution imaging experiments, they are the first to provide evidence that the PARK2 gene product Parkin is selectively recruited to damaged or uncoupled mitochondria. This recruitment leads to the clearance of the organelles through the autophagosome, demonstrating a primary function for Parkin in the regulation of mitochondrial turnover. This work significantly increases our understanding of PD and provides a new framework for the development of therapeutic interventions.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>McBride</LastName>
<ForeName>Heidi M</ForeName>
<Initials>HM</Initials>
<AffiliationInfo>
<Affiliation>University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7, Canada. hmcbride@ottawaheart.ca</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2008</Year>
<Month>11</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cell Biol</MedlineTA>
<NlmUniqueID>0375356</NlmUniqueID>
<ISSNLinking>0021-9525</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014475">Uncoupling Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.2.27</RegistryNumber>
<NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.2.27</RegistryNumber>
<NameOfSubstance UI="C111567">parkin protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Jun 29;441(7097):1157-61</RefSource>
<PMID Version="1">16672980</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2005 Nov 15;14(22):3477-92</RefSource>
<PMID Version="1">16207731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10793-8</RefSource>
<PMID Version="1">16818890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Autophagy. 2007 Jan-Feb;3(1):4-9</RefSource>
<PMID Version="1">16929167</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Cell Biol. 2007 Nov;9(11):1243-52</RefSource>
<PMID Version="1">17906618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2007 Nov 7;27(45):12413-8</RefSource>
<PMID Version="1">17989306</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18748-53</RefSource>
<PMID Version="1">18003894</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Novartis Found Symp. 2007;287:4-14; discussion 14-20</RefSource>
<PMID Version="1">18074628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2008 Jan;7(1):97-109</RefSource>
<PMID Version="1">18093566</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 2008 Jan 23;27(2):433-46</RefSource>
<PMID Version="1">18200046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1716-21</RefSource>
<PMID Version="1">18218782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1638-43</RefSource>
<PMID Version="1">18230723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2008 Feb 28;451(7182):1069-75</RefSource>
<PMID Version="1">18305538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2008 Apr;275(7):1384-91</RefSource>
<PMID Version="1">18279376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 May 13;105(19):7070-5</RefSource>
<PMID Version="1">18443288</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 2008 Aug;212(2):258-60</RefSource>
<PMID Version="1">18538324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):12022-7</RefSource>
<PMID Version="1">18687899</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14503-8</RefSource>
<PMID Version="1">18799731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2008 Dec 1;183(5):795-803</RefSource>
<PMID Version="1">19029340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Res. 2009 Jan;87(1):123-9</RefSource>
<PMID Version="1">18711745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2007 Jul;5(7):e172</RefSource>
<PMID Version="1">17579517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Jun 29;441(7097):1162-6</RefSource>
<PMID Version="1">16672981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2002 Sep 2;1592(1):89-96</RefSource>
<PMID Version="1">12191771</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2005 Jul 1;121(7):1085-95</RefSource>
<PMID Version="1">15989957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2005 Oct 24;579(25):5603-8</RefSource>
<PMID Version="1">16213503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Cell Biol. 2008 Dec 1;183(5):795-803</RefSource>
<PMID Version="1">19029340</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014475" MajorTopicYN="N">Uncoupling Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC2592834</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2008</Year>
<Month>11</Month>
<Day>26</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2008</Year>
<Month>12</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2008</Year>
<Month>11</Month>
<Day>26</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">19029341</ArticleId>
<ArticleId IdType="pii">jcb.200810184</ArticleId>
<ArticleId IdType="doi">10.1083/jcb.200810184</ArticleId>
<ArticleId IdType="pmc">PMC2592834</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Mcbride, Heidi M" sort="Mcbride, Heidi M" uniqKey="Mcbride H" first="Heidi M" last="Mcbride">Heidi M. Mcbride</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F28 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000F28 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:19029341
   |texte=   Parkin mitochondria in the autophagosome.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:19029341" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022